|
Anticoagulants
Citations 151-160 of 258 total displayed.
|
Past content
(since Jan 1999):
|
- Comments, Opinions, and Reviews
Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas
- Robert G. Hart, Silvina B. Tonarelli, and Lesly A. Pearce
Stroke 2005;36:1588-1593; published online before print as doi:10.1161/01.STR.0000170642.39876.f2
[Abstract]
[Full text]
- Articles
Thrombotic Risk Factors In Primary Antiphospholipid Syndrome. A 5-Year Prospective Study
- Maurizio Turiel, Piercarlo Sarzi-Puttini, Rossana Peretti, Edoardo Rossi, Fabiola Atzeni, Wendy Parsons, and Andrea Doria
Stroke published June 9, 2005, doi:10.1161/01.STR.0000170645.40562.09
[Abstract]
- Articles
Avoiding Central Nervous System Bleeding During Antithrombotic Therapy. Recent Data and Ideas
- Robert G. Hart, Silvina B. Tonarelli, and Lesly A. Pearce
Stroke published June 9, 2005, doi:10.1161/01.STR.0000170642.39876.f2
[Abstract]
- Articles
Therapy Implications of Transthoracic Echocardiography in Acute Ischemic Stroke Patients
- Tiago Tribolet de Abreu, Sónia Mateus, and José Correia
Stroke published June 9, 2005, doi:10.1161/01.STR.0000170636.08554.49
[Abstract]
- Original Contributions
Is Heparin Treatment the Optimal Management for Cerebral Venous Thrombosis?: Effect of Abciximab, Recombinant Tissue Plasminogen Activator, and Enoxaparin in Experimentally Induced Superior Sagittal Sinus Thrombosis
- Carina Röttger, Katharina Madlener, Matthias Heil, Tibo Gerriets, Maureen Walberer, Tiemo Wessels, Georg Bachmann, Manfred Kaps, and Erwin Stolz
Stroke 2005;36:841-846; published online before print as doi:10.1161/01.STR.0000157663.43209.a2
[Abstract]
[Full text]
- Cochrane Corner
Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonrheumatic Atrial Fibrillation and a History of Stroke or Transient Ischemic Attack
- Ritu Saxena and Peter J. Koudstaal
Stroke 2005;36:914-915; published online before print as doi:10.1161/01.STR.0000161710.96513.e2
[Full text]
- AHA/ASA Scientific Statement
Guidelines for the Early Management of Patients With Ischemic Stroke: 2005 Guidelines Update A Scientific Statement From the Stroke Council of the American Heart Association/American Stroke Association
- Harold Adams, Robert Adams, Gregory Del Zoppo, and Larry B. Goldstein
Stroke 2005;36:916-923, doi:10.1161/01.STR.0000163257.66207.2d
[Full text]
- Articles
Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonrheumatic Atrial Fibrillation and a History of Stroke or Transient Ischemic Attack
- Ritu Saxena and Peter J. Koudstaal
Stroke published March 10, 2005, doi:10.1161/01.STR.0000161710.96513.e2
[Abstract]
- Short Communications
Soluble Platelet Glycoprotein V Is a Marker of Thrombosis in Patients With Ischemic Stroke
- Valérie Wolff, Boris Aleil, Maurice Giroud, Jean-Louis Lorenzini, Nicolas Meyer, Marie-Louise Wiesel, Jean-Pierre Cazenave, and François Lanza
Stroke 2005;36:e17-19e; published online before print as doi:10.1161/01.STR.0000155738.02753.4d
[Abstract]
[Full text]
- Articles
Is Heparin Treatment the Optimal Management for Cerebral Venous Thrombosis? Effect of Abciximab, Recombinant Tissue Plasminogen Activator, and Enoxaparin in Experimentally Induced Superior Sagittal Sinus Thrombosis
- Carina Röttger, Katharina Madlener, Matthias Heil, Tibo Gerriets, Maureen Walberer, Tiemo Wessels, Georg Bachmann, Manfred Kaps, and Erwin Stolz
Stroke published February 24, 2005, doi:10.1161/01.STR.0000157663.43209.a2
[Abstract]
|
|
